Differential Proteome Analysis Identifies TGF-[beta]-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model
Transforming growth factor-[beta] (TGF-[beta]) has a dual role in tumorigenesis, acting as either a tumor suppressor or as a pro-oncogenic factor in a context-dependent manner. Although TGF-[beta] antagonists have been proposed as anti-metastatic therapies for patients with advanced stage cancer, ho...
Gespeichert in:
Veröffentlicht in: | PloS one 2015-05, Vol.10 (5) |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | |
container_title | PloS one |
container_volume | 10 |
creator | Sato, Misako Matsubara, Tsutomu Adachi, Jun Hashimoto, Yuuki Fukamizu, Kazuna Kishida, Marina Yang, Yu-an Wakefield, Lalage M Tomonaga, Takeshi |
description | Transforming growth factor-[beta] (TGF-[beta]) has a dual role in tumorigenesis, acting as either a tumor suppressor or as a pro-oncogenic factor in a context-dependent manner. Although TGF-[beta] antagonists have been proposed as anti-metastatic therapies for patients with advanced stage cancer, how TGF-[beta] mediates metastasis-promoting effects is poorly understood. Establishment of TGF-[beta]-related protein expression signatures at the metastatic site could provide new mechanistic information and potentially allow identification of novel biomarkers for clinical intervention to discriminate TGF-[beta] oncogenic effects from tumor suppressive effects. In the present study, we found that systemic administration of the TGF-[beta] receptor kinase inhibitor, SB-431542, significantly inhibited lung metastasis from transplanted 4T1 mammary tumors in Balb/c mice. The differentially expressed proteins in the comparison of lung metastases from SB-431542 treated and control vehicle-treated groups were analyzed by a quantitative LTQ Orbitrap Velos system coupled with stable isotope dimethyl labeling. A total of 36,239 peptides from 6,694 proteins were identified, out of which 4,531 proteins were characterized as differentially expressed. A subset of upregulated proteins in the control group was validated by western blotting and immunohistochemistry. The eukaryotic initiation factor (eIF) family members constituted the most enriched protein pathway in vehicle-treated compared with SB-43512-treated lung metastases, suggesting that increased protein expression of specific eIF family members, especially eIF4A1 and eEF2, is related to the metastatic phenotype of advanced breast cancer and can be down-regulated by TGF-[beta] pathway inhibitors. Thus our proteomic approach identified eIF pathway proteins as novel potential mediators of TGF-[beta] tumor-promoting activity. |
doi_str_mv | 10.1371/journal.pone.0126483 |
format | Article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A432244108</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A432244108</galeid><sourcerecordid>A432244108</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1668-461d8d5ecdafeeb4bb63605cfb2ceaeb949ff0dadd727ffe7a27c0e20597bd0e3</originalsourceid><addsrcrecordid>eNqN0EFLwzAUB_AiCs7pN_AQEAQPrUnapu1xTjcHG5M5vYiMNHnZMrpUmhTmtzdjHjbwIDkkvPf7P3gJgmuCIxJn5H5dt43hVfRVG4gwoSzJ45OgQ4qYhozi-PTgfR5cWLvGOI1zxjrB9lErBQ0Yp3mFXpraQb0B1PPjvq22aCR3LaXBovlwEH6U4PhnOIOKO5A7H058xTrutNjHtbFIG8RRMido0jbaAHpowBvU50ZAgya1hOoyOFO8snD1e3eDt8HTvP8cjqfDUb83DpeEsTxMGJG5TEFIrgDKpCxZzHAqVEkFcCiLpFAKSy5lRjO_ScZpJjBQnBZZKTHE3eBmP3fJK1hoo2rXcLHRVix6SUxpkhCcexX9ofyRsNHCf6vSvn4UuDsKeONg65a8tXYxep39307fj-3tgV0Br9zK1lXrdG3sIfwBka2a6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Differential Proteome Analysis Identifies TGF-[beta]-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model</title><source>PubMed Central Free</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Sato, Misako ; Matsubara, Tsutomu ; Adachi, Jun ; Hashimoto, Yuuki ; Fukamizu, Kazuna ; Kishida, Marina ; Yang, Yu-an ; Wakefield, Lalage M ; Tomonaga, Takeshi</creator><creatorcontrib>Sato, Misako ; Matsubara, Tsutomu ; Adachi, Jun ; Hashimoto, Yuuki ; Fukamizu, Kazuna ; Kishida, Marina ; Yang, Yu-an ; Wakefield, Lalage M ; Tomonaga, Takeshi</creatorcontrib><description>Transforming growth factor-[beta] (TGF-[beta]) has a dual role in tumorigenesis, acting as either a tumor suppressor or as a pro-oncogenic factor in a context-dependent manner. Although TGF-[beta] antagonists have been proposed as anti-metastatic therapies for patients with advanced stage cancer, how TGF-[beta] mediates metastasis-promoting effects is poorly understood. Establishment of TGF-[beta]-related protein expression signatures at the metastatic site could provide new mechanistic information and potentially allow identification of novel biomarkers for clinical intervention to discriminate TGF-[beta] oncogenic effects from tumor suppressive effects. In the present study, we found that systemic administration of the TGF-[beta] receptor kinase inhibitor, SB-431542, significantly inhibited lung metastasis from transplanted 4T1 mammary tumors in Balb/c mice. The differentially expressed proteins in the comparison of lung metastases from SB-431542 treated and control vehicle-treated groups were analyzed by a quantitative LTQ Orbitrap Velos system coupled with stable isotope dimethyl labeling. A total of 36,239 peptides from 6,694 proteins were identified, out of which 4,531 proteins were characterized as differentially expressed. A subset of upregulated proteins in the control group was validated by western blotting and immunohistochemistry. The eukaryotic initiation factor (eIF) family members constituted the most enriched protein pathway in vehicle-treated compared with SB-43512-treated lung metastases, suggesting that increased protein expression of specific eIF family members, especially eIF4A1 and eEF2, is related to the metastatic phenotype of advanced breast cancer and can be down-regulated by TGF-[beta] pathway inhibitors. Thus our proteomic approach identified eIF pathway proteins as novel potential mediators of TGF-[beta] tumor-promoting activity.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0126483</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Breast cancer ; Development and progression ; Gene expression ; Genetic aspects ; Health aspects ; Transforming growth factors</subject><ispartof>PloS one, 2015-05, Vol.10 (5)</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Sato, Misako</creatorcontrib><creatorcontrib>Matsubara, Tsutomu</creatorcontrib><creatorcontrib>Adachi, Jun</creatorcontrib><creatorcontrib>Hashimoto, Yuuki</creatorcontrib><creatorcontrib>Fukamizu, Kazuna</creatorcontrib><creatorcontrib>Kishida, Marina</creatorcontrib><creatorcontrib>Yang, Yu-an</creatorcontrib><creatorcontrib>Wakefield, Lalage M</creatorcontrib><creatorcontrib>Tomonaga, Takeshi</creatorcontrib><title>Differential Proteome Analysis Identifies TGF-[beta]-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model</title><title>PloS one</title><description>Transforming growth factor-[beta] (TGF-[beta]) has a dual role in tumorigenesis, acting as either a tumor suppressor or as a pro-oncogenic factor in a context-dependent manner. Although TGF-[beta] antagonists have been proposed as anti-metastatic therapies for patients with advanced stage cancer, how TGF-[beta] mediates metastasis-promoting effects is poorly understood. Establishment of TGF-[beta]-related protein expression signatures at the metastatic site could provide new mechanistic information and potentially allow identification of novel biomarkers for clinical intervention to discriminate TGF-[beta] oncogenic effects from tumor suppressive effects. In the present study, we found that systemic administration of the TGF-[beta] receptor kinase inhibitor, SB-431542, significantly inhibited lung metastasis from transplanted 4T1 mammary tumors in Balb/c mice. The differentially expressed proteins in the comparison of lung metastases from SB-431542 treated and control vehicle-treated groups were analyzed by a quantitative LTQ Orbitrap Velos system coupled with stable isotope dimethyl labeling. A total of 36,239 peptides from 6,694 proteins were identified, out of which 4,531 proteins were characterized as differentially expressed. A subset of upregulated proteins in the control group was validated by western blotting and immunohistochemistry. The eukaryotic initiation factor (eIF) family members constituted the most enriched protein pathway in vehicle-treated compared with SB-43512-treated lung metastases, suggesting that increased protein expression of specific eIF family members, especially eIF4A1 and eEF2, is related to the metastatic phenotype of advanced breast cancer and can be down-regulated by TGF-[beta] pathway inhibitors. Thus our proteomic approach identified eIF pathway proteins as novel potential mediators of TGF-[beta] tumor-promoting activity.</description><subject>Breast cancer</subject><subject>Development and progression</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Transforming growth factors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqN0EFLwzAUB_AiCs7pN_AQEAQPrUnapu1xTjcHG5M5vYiMNHnZMrpUmhTmtzdjHjbwIDkkvPf7P3gJgmuCIxJn5H5dt43hVfRVG4gwoSzJ45OgQ4qYhozi-PTgfR5cWLvGOI1zxjrB9lErBQ0Yp3mFXpraQb0B1PPjvq22aCR3LaXBovlwEH6U4PhnOIOKO5A7H058xTrutNjHtbFIG8RRMido0jbaAHpowBvU50ZAgya1hOoyOFO8snD1e3eDt8HTvP8cjqfDUb83DpeEsTxMGJG5TEFIrgDKpCxZzHAqVEkFcCiLpFAKSy5lRjO_ScZpJjBQnBZZKTHE3eBmP3fJK1hoo2rXcLHRVix6SUxpkhCcexX9ofyRsNHCf6vSvn4UuDsKeONg65a8tXYxep39307fj-3tgV0Br9zK1lXrdG3sIfwBka2a6Q</recordid><startdate>20150518</startdate><enddate>20150518</enddate><creator>Sato, Misako</creator><creator>Matsubara, Tsutomu</creator><creator>Adachi, Jun</creator><creator>Hashimoto, Yuuki</creator><creator>Fukamizu, Kazuna</creator><creator>Kishida, Marina</creator><creator>Yang, Yu-an</creator><creator>Wakefield, Lalage M</creator><creator>Tomonaga, Takeshi</creator><general>Public Library of Science</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20150518</creationdate><title>Differential Proteome Analysis Identifies TGF-[beta]-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model</title><author>Sato, Misako ; Matsubara, Tsutomu ; Adachi, Jun ; Hashimoto, Yuuki ; Fukamizu, Kazuna ; Kishida, Marina ; Yang, Yu-an ; Wakefield, Lalage M ; Tomonaga, Takeshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1668-461d8d5ecdafeeb4bb63605cfb2ceaeb949ff0dadd727ffe7a27c0e20597bd0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Breast cancer</topic><topic>Development and progression</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Transforming growth factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Misako</creatorcontrib><creatorcontrib>Matsubara, Tsutomu</creatorcontrib><creatorcontrib>Adachi, Jun</creatorcontrib><creatorcontrib>Hashimoto, Yuuki</creatorcontrib><creatorcontrib>Fukamizu, Kazuna</creatorcontrib><creatorcontrib>Kishida, Marina</creatorcontrib><creatorcontrib>Yang, Yu-an</creatorcontrib><creatorcontrib>Wakefield, Lalage M</creatorcontrib><creatorcontrib>Tomonaga, Takeshi</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Misako</au><au>Matsubara, Tsutomu</au><au>Adachi, Jun</au><au>Hashimoto, Yuuki</au><au>Fukamizu, Kazuna</au><au>Kishida, Marina</au><au>Yang, Yu-an</au><au>Wakefield, Lalage M</au><au>Tomonaga, Takeshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Proteome Analysis Identifies TGF-[beta]-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model</atitle><jtitle>PloS one</jtitle><date>2015-05-18</date><risdate>2015</risdate><volume>10</volume><issue>5</issue><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Transforming growth factor-[beta] (TGF-[beta]) has a dual role in tumorigenesis, acting as either a tumor suppressor or as a pro-oncogenic factor in a context-dependent manner. Although TGF-[beta] antagonists have been proposed as anti-metastatic therapies for patients with advanced stage cancer, how TGF-[beta] mediates metastasis-promoting effects is poorly understood. Establishment of TGF-[beta]-related protein expression signatures at the metastatic site could provide new mechanistic information and potentially allow identification of novel biomarkers for clinical intervention to discriminate TGF-[beta] oncogenic effects from tumor suppressive effects. In the present study, we found that systemic administration of the TGF-[beta] receptor kinase inhibitor, SB-431542, significantly inhibited lung metastasis from transplanted 4T1 mammary tumors in Balb/c mice. The differentially expressed proteins in the comparison of lung metastases from SB-431542 treated and control vehicle-treated groups were analyzed by a quantitative LTQ Orbitrap Velos system coupled with stable isotope dimethyl labeling. A total of 36,239 peptides from 6,694 proteins were identified, out of which 4,531 proteins were characterized as differentially expressed. A subset of upregulated proteins in the control group was validated by western blotting and immunohistochemistry. The eukaryotic initiation factor (eIF) family members constituted the most enriched protein pathway in vehicle-treated compared with SB-43512-treated lung metastases, suggesting that increased protein expression of specific eIF family members, especially eIF4A1 and eEF2, is related to the metastatic phenotype of advanced breast cancer and can be down-regulated by TGF-[beta] pathway inhibitors. Thus our proteomic approach identified eIF pathway proteins as novel potential mediators of TGF-[beta] tumor-promoting activity.</abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0126483</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2015-05, Vol.10 (5) |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_gale_infotracmisc_A432244108 |
source | PubMed Central Free; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry |
subjects | Breast cancer Development and progression Gene expression Genetic aspects Health aspects Transforming growth factors |
title | Differential Proteome Analysis Identifies TGF-[beta]-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A17%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Proteome%20Analysis%20Identifies%20TGF-%5Bbeta%5D-Related%20Pro-Metastatic%20Proteins%20in%20a%204T1%20Murine%20Breast%20Cancer%20Model&rft.jtitle=PloS%20one&rft.au=Sato,%20Misako&rft.date=2015-05-18&rft.volume=10&rft.issue=5&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0126483&rft_dat=%3Cgale%3EA432244108%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A432244108&rfr_iscdi=true |